back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-03-11 Tx date 2019-03-07 |
$FIRE
The Supreme Cannabis Company, Inc. |
Gehlsen, Cailin B.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-41,600
-20,000 vol $2.08 each |
0 | |
| Filed 2018-04-03 Tx date 2018-03-29 |
$FIRE
The Supreme Cannabis Company, Inc. |
Gehlsen, Cailin B.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
365,000 | |
| Filed 2018-01-05 Tx date 2018-01-02 |
$FIRE
The Supreme Cannabis Company, Inc. |
Gehlsen, Cailin B.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-49,800
-20,000 vol $2.49 each |
20,000 | |
| Filed 2017-09-29 Tx date 2017-09-25 |
$FIRE
Supreme Pharmaceuticals Inc. |
Gehlsen, Cailin B.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
325,000 | |
| Filed 2016-09-02 Tx date 2016-08-29 |
$SL
Supreme Pharmaceuticals Inc. |
Gehlsen, Cailin B.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
+100,000 vol |
175,000 | |
| Filed 2016-03-18 Tx date 2016-03-18 |
$SL
Supreme Pharmaceuticals Inc. |
Gehlsen, Cailin B.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+25,000 vol |
40,000 | |
| Filed 2016-03-04 Tx date 2015-10-22 |
$SL
Supreme Pharmaceuticals Inc. |
Gehlsen, Cailin B.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-04 Tx date 2016-01-10 |
$SL
Supreme Pharmaceuticals Inc. |
Gehlsen, Cailin B.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+75,000 vol |
75,000 | |
| Filed 2015-10-30 Tx date 2015-10-22 |
$SL
Supreme Pharmaceuticals Inc. |
Gehlsen, Cailin B.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
15,000 |